MARK VANDIEN: Open Payments
NPI 1194951905 · QUEENSBURY, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$542 in 29 payments from 13 companies in 2025. Trend: 2023 $281 · 2024 $531 · 2025 $542
Food & beverage: $542
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 5 | $114 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $60 |
| PFIZER INC. | 3 | $58 |
| SCPHARMACEUTICALS INC. | 3 | $54 |
| E.R. Squibb & Sons, L.L.C. | 3 | $47 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 2 | $34 |
| Baxter Healthcare | 1 | $33 |
| CVRx, Inc. | 2 | $33 |
| Amgen Inc. | 2 | $30 |
| Abbott Laboratories | 1 | $25 |
Products named: LEQVIO, JARDIANCE, ELIQUIS, FUROSCIX, CAMZYOS, LifeVest, Hillrom - Carnation Ambulatory Monitor, Barostim Neo System.
Industry payments across NY — which companies pay providers there.
